Anxiety and depression among opiate users who misuse substances during treatment

Irish Journal of Psychological Medicine

Volumn 28, Issue 1, 2011, Pages 6-12

  Stapleton, Robert ^a   Comiskey, Catherine ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Anxiety; Cocaine; Depression; Opiates; Treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; ILLICIT DRUG; METHADONE;

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG MISUSE; FEMALE; HEROIN DEPENDENCE; HOPELESSNESS; HUMAN; LONELINESS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; OUTCOME ASSESSMENT; SUBSTANCE ABUSE; SUICIDAL IDEATION; SUICIDE ATTEMPT;

EID: 81555221720     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700011848     Document Type: Article

References (26)

1. Woody GE, Blaine J. Depression in narcotic addicts: Quite possibly more than a chance association. In: Dupont RL, goldstein A, O'Donnell J, brown B (eds). Handbook on drug abuse. Washington, DC: US government Printing Office, 1979: 277-285.
2. Üstun TB, Ayuso-Mateos JL, Chatterji S, Methers C, Murray CJL. global burden of depressive disorders in the year 2000. br J Psychiatry 2004; 184: 386-392.
3. Kessler R, McGonagle K, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch gen Psychiatry 1994; 51: 8-19.
4. Wittchen H-U, Jacobi F. Size and burden of mental disorders in europe-a critical review of appraisal of 27 studies. Eur J Neuropharmacol 2005; 15, 357-376.
5. Brienza RS, Stein MD, Chen MH et al. Depression among needle exchange program and methadone maintenance clients. J Substance Abuse Treat 2000; 18: 331-337.
6. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment seeking opioid abusers. Arch Gen Psychiatry 1997; 54: 71-80.
7. Havard A, Teesson M, Darke S, Ross J. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). J Substance Abuse Treat 2006; 30: 355-362.
8. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence: Intake data from the National Treatment Outcome Research Study. br J Psychiatry 2000; 176: 285-289.
9. Rounsaville BJ, Weissman MM, Crits-Cristoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Arch gen Psychiatry 1982; 39: 151-156.
10. Merrikangas K, Mehta R, Molnar BE et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addictive Behaviour 1998; 23: 893-907.
11. Teesson M, Hall W, Lynskey M, Degenhardt L. Alcohol and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2000; 34, 206-213.
12. Jané-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006; 25: 515-536.
13. Nunes EV, Rounsaville BJ. Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV) to DSM-V. Addiction 2006; 101: 59-96.
14. Best D, Gossop M, Man L, Finch R, Greenwood J, Strang J. Accidental and deliberate overdose among opiate addicts in methadone maintenance treatment: Are deliberate overdoses systematically different? Drug Alcohol Rev 2000; 19: 213-216.
15. Chatham LR, Knight K, Joe GW, Simpson DD. Suicidality in a sample of methadone maintenance patients. Am J Drug Alcohol Abuse 1995; 21: 345-361.
16. Harris EC, barraclough b. Suicide as an outcome for mental disorders. br J Psychiatry 1997; 170: 205-228.
17. Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users: epidemiology, causes and intervention. Cambridge University Press: Cambridge, 2006.
18. Hickman M, Hope V, Coleman B et al. Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. J Public Health 2009; 31: 374-382.
19. Maxwell JC, Pullum TW, Tannert K. Deaths of clients in methadone treatment in Texas, 1994-2002. Drug Alcohol Dependence 2005; 78: 73-81.
20. Rehm J, Frick U, Hartwig C, Gutzwiller F, Gschwend P, Uchtenhagen A. Mortality in heroin assisted treatment in Switzerland 1994-2000. Drug Alcohol Dependence 2005; 79: 137-143.
21. Kessler R. The epidemiology of dual diagnosis. biol J Psychiatry 2004; 456: 730-737.
22. Hasin D, Nunes E, Meydan J. Comorbidity of alcohol, drug and psychiatric disorders: epidemiology. In: HR Kranzler, JA Tinsley, eds. Dual Diagnosis and Treatment: substance abuse and comorbid disorders. New York: Marcel Dekker, 2004: 1-30.
23. Marsden J, Gossop M, Stewart D et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998; 93: 1857-67.
24. Stapleton RD, Comiskey C. Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland. Drug Alcohol Dependence 2010; 107: 56-61.
25. Comiskey C, Stapleton R. Treatment pathways and longitudinal outcomes for opiate users: Implications for treatment policy and planning. Drugs: education, Prevention & Policy 2010; 17(6): 707-717.
26. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse: Results From the epidemiologic Catchment Area (eCA) Study. JAMA 1990; 264: 2511-2518.